{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:34:55Z","timestamp":1786980895160,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T00:00:00Z","timestamp":1563235200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T00:00:00Z","timestamp":1563235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100007684","name":"Ministry of Education and Science of Ukraine","doi-asserted-by":"crossref","award":["0118U000244"],"award-info":[{"award-number":["0118U000244"]}],"id":[{"id":"10.13039\/501100007684","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s10620-019-05730-3","type":"journal-article","created":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T02:02:51Z","timestamp":1563242571000},"page":"215-224","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Effects of Pristine C60 Fullerenes on Liver and Pancreas in \u03b1-Naphthylisothiocyanate-Induced Cholangitis"],"prefix":"10.1007","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1296-1007","authenticated-orcid":false,"given":"Halyna M.","family":"Kuznietsova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia V.","family":"Dziubenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana V.","family":"Lynchak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetyana S.","family":"Herheliuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmytro K.","family":"Zavalny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga V.","family":"Remeniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriy I.","family":"Prylutskyy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,16]]},"reference":[{"key":"5730_CR1","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/hep.24247","volume":"53","author":"NA Molodecky","year":"2011","unstructured":"Molodecky NA, Kareemi H, Parab R, et al. Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis. Hepatology. 2011;53:1590\u20131599.","journal-title":"Hepatology"},{"key":"5730_CR2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2147\/CEG.S105872","volume":"10","author":"S Sirpal","year":"2017","unstructured":"Sirpal S, Chandok N. Primary sclerosing cholangitis: diagnostic and management challenges. Clin Exp Gastroenterol. 2017;10:265\u2013273.","journal-title":"Clin Exp Gastroenterol"},{"key":"5730_CR3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","volume":"67","author":"GM Hirschfield","year":"2017","unstructured":"Hirschfield GM, Beuers U, Corpechot C, et al. EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017;67:145\u2013172.","journal-title":"J Hepatol"},{"key":"5730_CR4","doi-asserted-by":"crossref","first-page":"26757","DOI":"10.18632\/oncotarget.5610","volume":"6","author":"GQ Zhu","year":"2015","unstructured":"Zhu GQ, Shi KQ, Huang GQ, et al. A network meta-analysis of the efficacy and side effects of UDCA-based therapies for primary sclerosing cholangitis. Oncotarget. 2015;6:26757\u201326769.","journal-title":"Oncotarget"},{"key":"5730_CR5","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1007\/s10620-007-0052-6","volume":"53","author":"P Angulo","year":"2008","unstructured":"Angulo P, Jorgensen RA, Kowdley KV, et al. Silymarin in the treatment of patients with primary sclerosing cholangitis: an open-label pilot study. Dig Dis Sci. 2008;53:1716\u20131720. \nhttps:\/\/doi.org\/10.1007\/s10620-007-0052-6\n\n.","journal-title":"Dig Dis Sci"},{"key":"5730_CR6","doi-asserted-by":"crossref","first-page":"5137431","DOI":"10.1155\/2016\/5137431","volume":"2016","author":"MA Islam","year":"2016","unstructured":"Islam MA, Alam F, Solayman M, et al. Dietary phytochemicals: natural swords combating inflammation and oxidation-mediated degenerative diseases. Oxid Med Cell Longev. 2016;2016:5137431.","journal-title":"Oxid Med Cell Longev"},{"key":"5730_CR7","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.redox.2016.12.011","volume":"11","author":"J Morrya","year":"2017","unstructured":"Morrya J, Ngamcherdtrakula W, Yantasee W. Oxidative stress in cancer and fibrosis: opportunity for therapeutic intervention with antioxidant compounds, enzymes, and nanoparticles. Redox Biol. 2017;11:240\u2013253.","journal-title":"Redox Biol"},{"key":"5730_CR8","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1021\/nl051866b","volume":"5","author":"N Gharbi","year":"2005","unstructured":"Gharbi N, Pressac M, Hadchouel M, et al. [60] Fullerene is a powerful antioxidant in vivo with no acute or subacute toxicity. Nano Lett. 2005;5:2578\u20132585.","journal-title":"Nano Lett"},{"key":"5730_CR9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s11671-016-1775-0","volume":"12","author":"OV Lynchak","year":"2017","unstructured":"Lynchak OV, Prylutskyy YI, Rybalchenko VK, et al. Comparative analysis of the antineoplastic activity of C60 fullerene with 5-fluorouracil and pyrrole derivative in vivo. Nanoscale Res Lett. 2017;12:8.","journal-title":"Nanoscale Res Lett"},{"key":"5730_CR10","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.18520\/cs\/v114\/i09\/1846-1850","volume":"114","author":"SV Eswaran","year":"2018","unstructured":"Eswaran SV. Water soluble nanocarbon materials: a panacea for all? Curr Sci. 2018;114:1846\u20131850.","journal-title":"Curr Sci"},{"key":"5730_CR11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12951-016-0246-1","volume":"15","author":"YI Prylutskyy","year":"2017","unstructured":"Prylutskyy YI, Vereshchaka IV, Maznychenko AV, et al. C60 fullerene as promising therapeutic agent for correcting and preventing skeletal muscle fatigue. J Nanobiotechnol. 2017;15:8.","journal-title":"J Nanobiotechnol"},{"key":"5730_CR12","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1080\/1536383X.2014.949695","volume":"23","author":"OD Hendrickson","year":"2015","unstructured":"Hendrickson OD, Morozova OV, Zherdev AV, et al. Study of distribution and biological effects of fullerene C60 after single and multiple intragastrical administrations to rats. Fuller Nanotub Carbon Nanostruct. 2015;23:658\u2013668.","journal-title":"Fuller Nanotub Carbon Nanostruct"},{"key":"5730_CR13","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/jat.3110","volume":"35","author":"SCJ Sumner","year":"2015","unstructured":"Sumner SCJ, Snyder RW, Wingard C, et al. Distribution and biomarkers of carbon-14-labeled fullerene C60 ([14C(U)]C60) in female rats and mice for up to 30\u00a0days after intravenous exposure. J Appl Toxicol. 2015;35:1452\u20131464.","journal-title":"J Appl Toxicol"},{"key":"5730_CR14","doi-asserted-by":"crossref","first-page":"100046","DOI":"10.1039\/C6RA20291H","volume":"6","author":"TI Halenova","year":"2016","unstructured":"Halenova TI, Vareniuk IM, Roslova NM, et al. Hepatoprotective effect of orally applied water-soluble pristine C60 fullerene against CCl4-induced acute liver injury in rats. RSC Adv. 2016;6:100046\u2013100055.","journal-title":"RSC Adv"},{"key":"5730_CR15","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.msec.2018.08.033","volume":"93","author":"IV Byelinska","year":"2018","unstructured":"Byelinska IV, Kuznietsova HM, Dziubenko NV, et al. Effect of C60 fullerenes on the intensity of colon damage and hematological signs of ulcerative colitis in rats. Mater Sci Eng C. 2018;93:505\u2013517.","journal-title":"Mater Sci Eng C"},{"key":"5730_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s13204-018-0700-5","author":"HM Kuznietsova","year":"2018","unstructured":"Kuznietsova HM, Lynchak OV, Dziubenko NV, et al. Water-soluble C60 fullerenes reduce manifestations of acute cholangitis in rats. Appl Nanosci. 2018. \nhttps:\/\/doi.org\/10.1007\/s13204-018-0700-5\n\n.","journal-title":"Appl Nanosci"},{"key":"5730_CR17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0928-4931(02)00244-8","volume":"23","author":"YI Prylutskyy","year":"2003","unstructured":"Prylutskyy YI, Yashchuk VM, Kushnir KM, et al. Biophysical studies of fullerene-based composite for bio-nanotechnology. Mater Sci Eng C. 2003;23:109\u2013111.","journal-title":"Mater Sci Eng C"},{"key":"5730_CR18","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1080\/1536383X.2013.870900","volume":"23","author":"U Ritter","year":"2015","unstructured":"Ritter U, Prylutskyy YI, Evstigneev MP, et al. Structural features of highly stable reproducible C60 fullerene aqueous colloid solution probed by various techniques. Fuller Nanotub Carbon Nanostruct. 2015;23:530\u2013534.","journal-title":"Fuller Nanotub Carbon Nanostruct"},{"key":"5730_CR19","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jhep.2014.02.006","volume":"60","author":"P Fickert","year":"2014","unstructured":"Fickert P, Pollheimer MJ, Beuers U, et al. Characterization of animal models for primary sclerosing cholangitis (PSC). J Hepatol. 2014;60:1290\u20131303.","journal-title":"J Hepatol"},{"key":"5730_CR20","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2131\/jts.42.715","volume":"42","author":"MK Bothe","year":"2017","unstructured":"Bothe MK, Meyer C, Mueller U, et al. Characterization of a rat model of moderate liver dysfunction based on alpha-naphthylisothiocyanate-induced cholestasis. J Toxicol Sci. 2017;42:715\u2013721.","journal-title":"J Toxicol Sci"},{"key":"5730_CR21","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1503\/cmaj.1040752","volume":"172","author":"EG Giannini","year":"2005","unstructured":"Giannini EG, Testa R, Savarino V. Liver enzyme alteration: a guide for clinicians. CMAJ. 2005;172:367\u2013379.","journal-title":"CMAJ"},{"key":"5730_CR22","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1080\/15376516.2016.1190991","volume":"26","author":"B Cogliati","year":"2016","unstructured":"Cogliati B, Crespo Yanguas S, da Silva TC, et al. Connexin32 deficiency exacerbates carbon tetrachloride-induced hepatocellular injury and liver fibrosis in mice. Toxicol Mech Methods. 2016;26:362\u2013370.","journal-title":"Toxicol Mech Methods"},{"key":"5730_CR23","doi-asserted-by":"crossref","first-page":"S487","DOI":"10.1111\/j.1872-034X.2007.00235.x","volume":"37","author":"S Kawa","year":"2007","unstructured":"Kawa S, Hamano H, Umemura T, et al. Sclerosing cholangitis associated with autoimmune pancreatitis. Hepatol Res. 2007;37:S487\u2013S495.","journal-title":"Hepatol Res"},{"key":"5730_CR24","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","volume":"39","author":"M Valko","year":"2007","unstructured":"Valko M, Leibfritz D, Moncol J, et al. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39:44\u201384.","journal-title":"Int J Biochem Cell Biol"},{"key":"5730_CR25","doi-asserted-by":"crossref","first-page":"5746","DOI":"10.3748\/wjg.v20.i19.5746","volume":"20","author":"I Grattagliano","year":"2014","unstructured":"Grattagliano I, Calamita G, Cocco T, et al. Pathogenic role of oxidative and nitrosative stress in primary biliary cirrhosis. WJG. 2014;20:5746\u20135759.","journal-title":"WJG"},{"key":"5730_CR26","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.msec.2015.10.049","volume":"59","author":"Y Prylutskyy","year":"2016","unstructured":"Prylutskyy Y, Bychko A, Sokolova V, et al. Interaction of C60 fullerene complexed to doxorubicin with model bilipid membranes and its uptake by HeLa Cells. Mater Sci Eng C. 2016;59:398\u2013403.","journal-title":"Mater Sci Eng C"},{"key":"5730_CR27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s11671-016-1819-5","volume":"12","author":"D Franskevych","year":"2017","unstructured":"Franskevych D, Palyvoda K, Petukhov D, et al. Fullerene C60 penetration into leukemic cells and its photoinduced cytotoxic effects. Nanoscale Res Lett. 2017;12:40.","journal-title":"Nanoscale Res Lett"},{"key":"5730_CR28","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1002\/hep.22908","volume":"49","author":"H Yang","year":"2009","unstructured":"Yang H, Ramani K, Xia M, et al. Dysregulation of glutathione synthesis during cholestasis in mice: molecular mechanisms and therapeutic implications. Hepatology. 2009;49:1982\u20131991.","journal-title":"Hepatology"},{"key":"5730_CR29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molimm.2005.06.019","volume":"43","author":"MM Markiewski","year":"2006","unstructured":"Markiewski MM, DeAngelis RA, Lambris JD. Liver inflammation and regeneration: two distinct biological phenomena or parallel pathophysiological processes. Mol Immunol. 2006;43:45\u201356.","journal-title":"Mol Immunol"},{"key":"5730_CR30","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1186\/s13063-017-2134-x","volume":"18","author":"AA den Broeder","year":"2017","unstructured":"den Broeder AA, Verhoef LM, Fransen J, et al. Ultra-low dose of rituximab in rheumatoid arthritis: study protocol for a randomised controlled trial. Trials. 2017;18:403.","journal-title":"Trials"},{"key":"5730_CR31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejogrb.2017.08.023","volume":"217","author":"M Pir\u00f3g","year":"2017","unstructured":"Pir\u00f3g M, Jach R, Undas A. Effects of ultra-low-dose versus standard hormone therapy on fibrinolysis and thrombin generation in postmenopausal women. Eur J Obstet Gynecol Reprod Biol. 2017;217:77\u201382.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"5730_CR32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1055\/s-0038-1632362","volume":"107","author":"LB Boldyreva","year":"2018","unstructured":"Boldyreva LB. A theoretical approach to selection of a biologically active substance in ultra-low doses for effective action on a biological system. Homeopathy. 2018;107:137\u2013142.","journal-title":"Homeopathy"},{"key":"5730_CR33","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/mawe.201300082","volume":"44","author":"G Didenko","year":"2013","unstructured":"Didenko G, Prylutska S, Kichmarenko Y, et al. Evaluation of the antitumor immune response to C60 fullerene. Mat.-wiss u Werkstofftech. 2013;44:124\u2013128.","journal-title":"Mat.-wiss u Werkstofftech"},{"key":"5730_CR34","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1039\/C3NR05772K","volume":"6","author":"M Turabekova","year":"2014","unstructured":"Turabekova M, Rasulev B, Theodore M, et al. Immunotoxicity of nanoparticles: a computational study suggests that CNTs and C60 fullerenes might be recognized as pathogens by Toll-like receptors. Nanoscale. 2014;6:3488\u20133495.","journal-title":"Nanoscale"},{"key":"5730_CR35","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12645-017-0034-0","volume":"9","author":"LM Skivka","year":"2018","unstructured":"Skivka LM, Prylutska SV, Rudyk MP, et al. C60 fullerene and its nanocomplexes with anticancer drugs modulate circulating phagocyte functions and dramatically increase ROS generation in transformed monocytes. Cancer Nanotechnol. 2018;9:8.","journal-title":"Cancer Nanotechnol"},{"key":"5730_CR36","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.bbadis.2012.11.017","volume":"1832","author":"P Huebener","year":"2013","unstructured":"Huebener P, Schwabe RF. Regulation of wound healing and organ fibrosis by Toll-like receptors. Biochim Biophys Acta. 2013;1832:1005\u20131017.","journal-title":"Biochim Biophys Acta"},{"key":"5730_CR37","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","volume":"4","author":"TA Wynn","year":"2004","unstructured":"Wynn TA. Fibrotic disease and the Th1\/Th2 paradigm. Nat Rev Immunol. 2004;4:583\u2013594.","journal-title":"Nat Rev Immunol"},{"key":"5730_CR38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12951-016-0159-z","volume":"14","author":"N Shershakova","year":"2016","unstructured":"Shershakova N, Baraboshkina E, Andreev S, et al. Anti-inflammatory effect of fullerene C60 in a mice model of atopic dermatitis. J Nanobiotechnol. 2016;14:8.","journal-title":"J Nanobiotechnol"},{"key":"5730_CR39","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S1084952102001258","volume":"13","author":"L Libbrecht","year":"2002","unstructured":"Libbrecht L, Roskams T. Hepatic progenitor cells in human liver diseases. Semin Cell Dev Biol. 2002;13:389\u2013396.","journal-title":"Semin Cell Dev Biol"},{"key":"5730_CR40","doi-asserted-by":"crossref","first-page":"248920","DOI":"10.1155\/2015\/248920","volume":"2015","author":"IE Nygard","year":"2015","unstructured":"Nygard IE, Mortensen KE, Hedegaard J, et al. Tissue remodelling following resection of porcine liver. Biomed Res Int. 2015;2015:248920.","journal-title":"Biomed Res Int"},{"key":"5730_CR41","doi-asserted-by":"crossref","first-page":"e74141","DOI":"10.1371\/journal.pone.0074141","volume":"8","author":"S Wang","year":"2013","unstructured":"Wang S, Lee Y, Kim J, et al. Potential role of Hedgehog pathway in liver response to radiation. PLoS ONE. 2013;8:e74141.","journal-title":"PLoS ONE"},{"key":"5730_CR42","doi-asserted-by":"crossref","first-page":"e96185","DOI":"10.1371\/journal.pone.0096185","volume":"9","author":"J Li","year":"2014","unstructured":"Li J, Chen L, Zhang X, et al. Detection of circulating tumor cells in hepatocellular carcinoma using antibodies against asialoglycoprotein receptor, carbamoyl phosphate synthetase 1 and pan-cytokeratin. PLoS ONE. 2014;9:e96185.","journal-title":"PLoS ONE"},{"key":"5730_CR43","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev-pathol-052016-100322","volume":"12","author":"S Affo","year":"2016","unstructured":"Affo S, Yu LX, Schwabe RF. The role of cancer-associated fibroblasts and fibrosis in liver cancer. Annu Rev Pathol. 2016;12:153\u2013186.","journal-title":"Annu Rev Pathol."},{"key":"5730_CR44","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/labinvest.2014.94","volume":"94","author":"JH Tabibian","year":"2014","unstructured":"Tabibian JH, Trussoni CE, O\u2019Hara SP, et al. Characterization of cultured cholangiocytes isolated from livers of patients with primary sclerosing cholangitis. Lab Invest. 2014;94:1126\u20131133.","journal-title":"Lab Invest"},{"key":"5730_CR45","doi-asserted-by":"publisher","DOI":"10.5772\/33491","volume-title":"Cytokeratins - Tools in Oncology","author":"Priti Chougule","year":"2012","unstructured":"Chougule P, Sumitran-Holgersson S. Cytokeratins of the liver and intestine epithelial cells during development and disease. In: Hamilton G, ed. Cytokeratins\u2014Tools in Oncology. InTech; 2012. \nhttps:\/\/doi.org\/10.5772\/33491\n\n."},{"key":"5730_CR46","doi-asserted-by":"crossref","first-page":"F1422","DOI":"10.1152\/ajprenal.00319.2013","volume":"305","author":"P Ranganathan","year":"2013","unstructured":"Ranganathan P, Jayakumar C, Manicassamy S, et al. CXCR46 knockout mice are protected against DSS-colitis-induced acute kidney injury and inflammation. Am J Physiol Renal Physiol. 2013;305:F1422\u2013F1427.","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05730-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-019-05730-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05730-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T19:09:40Z","timestamp":1594753780000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-019-05730-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,16]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["5730"],"URL":"https:\/\/doi.org\/10.1007\/s10620-019-05730-3","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,16]]},"assertion":[{"value":"11 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All experiments with animals\u2019 use were conducted in compliance with bioethics principles, legislative norms, and provisions of the European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes (Strasbourg, 1986), General Ethical Principles for Experiments on Animals, adopted by the First National Bioethics Congress (Kyiv, 2001), and approved by an institutional review committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}